Galaxy Surfactants Ltd. · NSE:GALAXYSURF
Galaxy Surfactants — Q1 FY2026 Earnings Presentation
16 slides from Galaxy Surfactants's earnings presentation, Aug 13, 2025
Slide 1: Galaxy Surfactants Ltd. exchange filing letter
Galaxy Surfactants Ltd. August 13, 2025 National Stock Exchange of India Limited BSE Limited, Exchange Plaza, C-1, Block G, Listing Department, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East) Dalal Street, Mumbai – 400 051 Mumbai- 400001 Scrip Symbol: GALAXYSURF Scrip Code: 540935 Sub
Slide 2: Galaxy Surfactants Limited Result Presentation August'25
Galaxy Surfactants Limited Result Presentation August’25
Slide 3: Safe Harbor
Safe Harbor Z @a@ to6at Sag±lie ta (ta6at @ads This presentation and the accompanying slides (the “Presentation”), which have been prepared by Galaxy Surfactants Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation
Slide 4: Company at a Glance
Company at a Glance Z @a@ to6at Sag±lie ta (ta6at @ads Extensive R&D Capabilities 7 Strategically Located 215+ Product Grades Facilities with Inhouse Performance Surfactants: 47+ Speciality Care Products: 168+ 100+ Members R&D Centre Pilot Plant Product Application Centre t? Project Execution Capabi
Slide 5: Quarterly Performance Highlights
Quarterly Performance Highlights
Slide 6: Q1FY26: Key Developments
Q1FY26: Key Developments Z @a@ to6at Sag±lie ta (ta6at @ads 01 02 03 EBIDTA grew by 4.3% YoY in line with In Q1FY26, volumes grew by 5% YoY, volume growth ROW region experienced High double- with sequential growth nearing double digit volume driven by masstige digits across Performance and EBIDTA /M
Slide 7: Management Commentary
Management Commentary Z @a@ to6at Sag±lie ta (ta6at @ads I “Q1FY26 Volume grew at 5% YoY and nearly double-digit sequential across both performance and specialty care segments, reflecting a sign of improvement across all regions. India’s domestic performance reflects a market in transition and evolu
Slide 8: Q1FY26: Consolidated Financial Highlights
Q1FY26: Consolidated Financial Highlights Z @ a@ to6at Sag±lie ta (ta6at @ads ₹ In Crores --1__1-- --1__1-- ---1__1-- Total Revenue* EBITDA PAT +31.6% +4.3% -0.3% 1,289.2 135.1 79.7 79.5 129.5 979.5 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 L-------------------------- L-------------------------- L--
Slide 9: Q1FY26: Segment Performance Highlights
Q1FY26: Segment Performance Highlights Z @a@ to6at Sag±lie ta (ta6at @ads Segment-wise Revenue & Volume Performance Performance Surfactants Revenue Specialty Care Revenue Total Revenue ( ) ₹ 840.5 cr ₹ 448.6 cr c ) ₹ 1,289.2 cr Overall Volume growth remains Mid Single digit on YoY Region-wise Volume
Slide 10: Q1FY26: Revenue Performance
Q1FY26: Revenue Performance Z @a@ to6at Sag±lie ta (ta6at @ads Category Customer Region wise Revenue 49% 42% 44% 51% 59% 65% 11% 9% 23% 22% 41% 35% 38% 42% 35% 34% Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 - Performance Surfactants Speciality Care Products - MNC Customer Regional Players - Local & N
Slide 11: Managing Volatility in Raw Material Prices and Currency
Managing Volatility in Raw Material Prices and Currency... Z @a@ to6at Sag±lie ta (ta6at @ads Fatty Alcohol Prices (USD / MT) INR / USD Prices LA Price USDINR 90.00 3,000 86.00 2,600 2,200 82.00 1,800 78.00 1,400 74.00 1,000 70.00 LA Price USDINR … through Robust Risk Management Practices Source: Ma
Slide 12: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Z @a@ to6at Sag±lie ta (ta6at @ads Particulars (₹ In Crores) Q1FY26 Q1FY25 Y-o-Y Q4FY25 Q-o-Q FY25 Net Revenue from Operations 1,277.9 974.1 31.2% 1,144.9 11.6% 4,223.7 Other Income 11.2 5.4 7.8 25.8 Total Revenue 1,289.2 979.5 31.6% 1,152.7 11.8% 4,249.5 Cost of
Slide 13: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement Z @a@ to6at Sag±lie ta (ta6at @ads Particulars (₹. In Crores) Q1FY26 Q1FY25 Y-o-Y Q4FY25 Q-o-Q FY25 Net Revenue from Operations 874.1 677.5 29.0% 814.3 7.3% 3,001.3 Other Income 6.5 1.0 6.7 26.5 Total Revenue 880.6 678.5 29.8% 820.9 7.3% 3,027.7 Cost of Material Co
Slide 14: Vision 2030
Vision 2030 •• '• 13
Slide 15: Vision 2030: The Contours
Vision 2030: The Contours Z @a@ to6at Sag±lie ta (ta6at @ads 2x 2.5x 22%+ Volumes EBITDA ROCE Defend and Grow in India and AMET Winning in Americas Winning in Specialities in EU Focus Industry Performance Surfactants Specialty Care Products DEFEND & GROW ✓ HOME CARE ✓ AMET 3D ITT ✓ INDIA ✓ Developme
Slide 16: Thank You
Thank You Company Investor Relations Advisors : $GA Satesic Growt Advisors h CIN - U74140MH2010PTC204285 CIN No: L39877MH1986PLC039877 Mr. Mandar Chavan / Mr. Rahul Agarwal Mr. Ruchir Soni mandar.chavan@sgapl.net / Email: Ruchir.Soni@galaxysurfactants.com rahul.agarwal@sgapl.net www.galaxysurfactant